Amoy Diagnostics Future Growth
Future criteria checks 3/6
Amoy Diagnostics is forecast to grow earnings and revenue by 19.6% and 20.4% per annum respectively. EPS is expected to grow by 19.7% per annum. Return on equity is forecast to be 17.8% in 3 years.
Key information
19.6%
Earnings growth rate
19.7%
EPS growth rate
Biotechs earnings growth | 43.4% |
Revenue growth rate | 20.4% |
Future return on equity | 17.8% |
Analyst coverage | Good |
Last updated | 31 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,861 | 477 | 349 | 396 | 9 |
12/31/2025 | 1,545 | 389 | 302 | 297 | 10 |
12/31/2024 | 1,266 | 318 | 253 | 236 | 7 |
9/30/2024 | 1,184 | 315 | 289 | 324 | N/A |
6/30/2024 | 1,128 | 279 | 262 | 295 | N/A |
3/31/2024 | 1,082 | 268 | 274 | 312 | N/A |
12/31/2023 | 1,044 | 261 | 254 | 299 | N/A |
9/30/2023 | 951 | 213 | 222 | 269 | N/A |
6/30/2023 | 908 | 301 | 164 | 222 | N/A |
3/31/2023 | 831 | 267 | 108 | 189 | N/A |
1/1/2023 | 842 | 264 | 71 | 149 | N/A |
9/30/2022 | 871 | 287 | 75 | 140 | N/A |
6/30/2022 | 911 | 218 | 81 | 146 | N/A |
3/31/2022 | 949 | 250 | 88 | 134 | N/A |
1/1/2022 | 917 | 240 | 94 | 168 | N/A |
9/30/2021 | 890 | 231 | 107 | 196 | N/A |
6/30/2021 | 844 | 211 | 125 | 224 | N/A |
3/31/2021 | 811 | 198 | 143 | 235 | N/A |
12/31/2020 | 728 | 180 | 163 | 221 | N/A |
9/30/2020 | 650 | 153 | 114 | 167 | N/A |
6/30/2020 | 595 | 138 | 126 | 159 | N/A |
3/31/2020 | 550 | 129 | 143 | 170 | N/A |
12/31/2019 | 578 | 135 | 128 | 152 | N/A |
9/30/2019 | 541 | 140 | 126 | 153 | N/A |
6/30/2019 | 502 | 135 | 87 | 120 | N/A |
3/31/2019 | 469 | 134 | 66 | 104 | N/A |
12/31/2018 | 439 | 127 | 54 | 93 | N/A |
9/30/2018 | 398 | 122 | 71 | 108 | N/A |
6/30/2018 | 384 | 120 | N/A | 114 | N/A |
3/31/2018 | 357 | 103 | N/A | 96 | N/A |
12/31/2017 | 330 | 94 | N/A | 92 | N/A |
9/30/2017 | 315 | 82 | N/A | 70 | N/A |
6/30/2017 | 288 | 78 | N/A | 49 | N/A |
3/31/2017 | 258 | 67 | N/A | 40 | N/A |
12/31/2016 | 253 | 67 | N/A | 32 | N/A |
6/30/2016 | 220 | 42 | N/A | 24 | N/A |
3/31/2016 | 198 | 32 | N/A | 22 | N/A |
12/31/2015 | 177 | 21 | N/A | 19 | N/A |
12/31/2014 | 107 | 19 | N/A | 16 | N/A |
12/31/2013 | 74 | 22 | N/A | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300685's forecast earnings growth (19.6% per year) is above the savings rate (2.8%).
Earnings vs Market: 300685's earnings (19.6% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 300685's earnings are forecast to grow, but not significantly.
Revenue vs Market: 300685's revenue (20.4% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 300685's revenue (20.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300685's Return on Equity is forecast to be low in 3 years time (17.8%).